Molecular Partners

📍 Schlieren-Zürich, Switzerland🗓 Founded 2004👥 177 employees
Biotechnology Research🌐 molecularpartners.com
Website LinkedIn
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Molecular Partners founded?
Molecular Partners was founded in 2004.
What industry is Molecular Partners in?
Molecular Partners operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Molecular Partners based?
Molecular Partners is headquartered in Schlieren-Zürich, Switzerland.